These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6856611)

  • 1. [Possibilities of using Nootropyl in the treatment of tuberculosis].
    Sokolova GB; Ziia AV; Suvorova VI; Braude VI; Glik MS
    Probl Tuberk; 1983 Mar; (3):58-63. PubMed ID: 6856611
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for prevention of isoniazid-associated liver disease.
    Tizes R; Hayden CH; Perrin P
    JAMA; 1971 Dec; 218(11):1703. PubMed ID: 5171051
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic effects of Nootropyl].
    Houillon P; Kitenge A; Jouannigot R; Lullien L
    Ann Med Psychol (Paris); 1980; 138(7):869-76. PubMed ID: 7458110
    [No Abstract]   [Full Text] [Related]  

  • 4. [Nootropyl (piracetam)--memory disorders].
    Holmboe AM
    Tidsskr Nor Laegeforen; 1977 Feb; 97(6):309-10. PubMed ID: 847681
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of a isoniozid-rifompicin drug hepatotoxicity screening technic in tuberculosis therapy].
    Viteau JM; Toulet J; Plonteux G; Abiven M; Bonfante N
    Sem Hop; 1974 Jun; 50(28):1953-9. PubMed ID: 4374748
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: Isoniazid hepatitis.
    Ann Intern Med; 1974 Jan; 80(1):113-4. PubMed ID: 4810337
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: The isoniazid problem.
    Reichman LB
    Gastroenterology; 1976 Apr; 70(4):631-2. PubMed ID: 1254146
    [No Abstract]   [Full Text] [Related]  

  • 8. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis.
    Grönhagen-Riska C; Hellstrom PE; Fröseth B
    Am Rev Respir Dis; 1978 Sep; 118(3):461-6. PubMed ID: 707874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoniazid treatment for tuberculosis.
    Stadler ET; Steiner M
    N Engl J Med; 1971 Apr; 284(13):730-1. PubMed ID: 4993672
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: The isoniazid problem.
    Farer LS
    Gastroenterology; 1976 Apr; 70(4):631. PubMed ID: 1254145
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of preparations from the nootropic group for treating memory disorders in chronic alcoholism].
    Shabanov PD; Grinenko AIa; Kalishevich SIu
    Klin Med (Mosk); 1988 Sep; 66(9):114-6. PubMed ID: 3204950
    [No Abstract]   [Full Text] [Related]  

  • 12. Isoniazid-induced liver disease.
    Maddrey WC
    Semin Liver Dis; 1981 May; 1(2):129-33. PubMed ID: 7347016
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic trial of nootropyl in otorhinolaryngology].
    Ammar-Khodja A
    Rev Laryngol Otol Rhinol (Bord); 1974; 95(9-10):697-700. PubMed ID: 4462173
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hepatotoxicity of the rifampicin-isoniazid combination in children].
    Bonora G; De La Pierre L; Perletti L
    Minerva Pediatr; 1981 Aug; 33(16):835-6. PubMed ID: 7311946
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug prophylaxis of liver lesions induced by isoniazid and its metabolites].
    Sokolova GB; Nikolaev VP; Braude VI; Ziia AV
    Probl Tuberk; 1989; (5):36-40. PubMed ID: 2748556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical use of piracetam in chronic alcoholism and its complications predelirium and delirium].
    Ulbricht B
    Med Welt; 1976 Oct; 27(40):1912-5. PubMed ID: 790079
    [No Abstract]   [Full Text] [Related]  

  • 17. [Detection of the effects of the rifampin-isoniazid combination on the human liver].
    Plomteux G; Heusghem C; Ferdinande R; Lecoq A; Winandy A; Parmentier JC
    Nouv Presse Med; 1974 Mar; 3(12):727-32. PubMed ID: 4836506
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hepatic drug monitoring in patients exposed to antitubercular treatment].
    Domínguez JP; Amenábar E; Mendoza F; Pivet H; Palacios L; Lagos A; Diaz N; Calderón J; Cardenas R; Pérez-Olea J
    Rev Med Chil; 1982 Aug; 110(8):733-7. PubMed ID: 7156604
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatic damage caused by drugs and evaluation of the therapeutic effectiveness of pyridoxine pyrrolidone carboxylate].
    Nami R
    Clin Ter; 1979 Oct; 91(1):41-55. PubMed ID: 546575
    [No Abstract]   [Full Text] [Related]  

  • 20. [Information obtained by liver biopsy in 100 tuberculous patients].
    Morere P; Nouvet G; Stain JP; Paillot B; Metayer J; Hemet J
    Sem Hop; 1975 Jul 10-20; 51(31-34):2095-102. PubMed ID: 170685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.